Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA
Background: Despite having unquestionable glucose lowering efficacy, current guidelines no more favour the uses of sulphonylureas for CV safety concern, except when cost is an issue. However, formal cardiovascular outcome trial (CVOT) is not available. Materials and methods: We performed an indirect...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2020-11-01
|
| Sarja: | Diabetes & Vascular Disease Research |
| Linkit: | https://doi.org/10.1177/1479164120973653 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|